Choose the immune context
T-cell cytotoxic function and macrophage inflammatory polarization require different expertise, comparators and endpoints.
CRISPR / Research program K11
Proposed program · Specialist partners soughtImmune Function Partnerships
Give immune-cell research a sharper functional question.
The program question
Can a defined intervention improve a relevant immune function without creating an unwanted inflammatory or growth phenotype?
Evaluate qualified immunology partnerships around aged T-cell dysfunction and primary myeloid-cell screening. These are distinct research contexts, not one promise to rejuvenate the immune system.
Qualify the partner
Review the model, delivery setting, donor and material rights, output data, quality expectations and capacity before proposing a commissioned study.
Keep translation specific
Mouse tumor control and associative human observations remain distinct. Any later product needs its own clinical and delivery rationale.
What would justify the next step?
No therapeutic service or immune-cell product is offered. A study requires specialist accountability, appropriate facilities and project-specific review.
From question to decision
A program names the scientific direction. A project brief defines a proposed bounded work package. A commercial scope specifies what a buyer would receive and what must be qualified before contracting. These are related, but they are not interchangeable.
Research context
External work. Explicit limits.
2026-07-29 · United States
Animals + human association · Cas9 screenAged T-cell function: the intervention direction matters
Screens identified Dusp5 and Zfp219 as regulators of T-cell expansion or cytotoxic function. Zfp219 loss combined with checkpoint inhibition improved tumor control in aged mice; the human ZNF219 observations were associative.
- Target / subject
- Dusp5 / Zfp219; human ZNF219
- Direction
- Loss of function; combination with checkpoint inhibition
- Cell / setting
- T cells in an aged tumor environment
- Boundary
- Mouse tumor control is not proof of general human immune rejuvenation. Dusp5, Zfp219 and human ZNF219 cannot be used interchangeably.
2026-08-17 · Not assigned
Primary human cells · Cas9 screenPrimary myeloid screens reveal context-specific inflammatory effects
Virus-like particle tools enabled targeted engineering and pooled screening of primary human myeloid cells. In the macrophage context highlighted in the assessment, disrupting TNFAIP3 promoted inflammation.
- Target / subject
- TNFAIP3 and other regulators
- Direction
- Disruption; context-dependent inflammation
- Cell / setting
- Monocytes, macrophages and dendritic cells
- Boundary
- A gene name is not an intervention recommendation. An effect can have the opposite direction from what another cell type or disease context might suggest.
2026-08-28 · South Korea
Cells + animals · Prime editingPrime assembly: large DNA changes remain context-specific
The assessment describes donor-directed annealing with prime editing for large genomic replacement. One reported application was targeted CAR insertion into primary human T cells, with efficiency up to 28.1%.
- Target / subject
- Targeted integration sites
- Direction
- Targeted integration / replacement
- Cell / setting
- Primary human T cells and additional experimental systems
- Boundary
- Cell-line maxima, primary-cell results and mouse delivery are different experiments. They cannot be combined into one general performance promise or a claim of age reversal.
Source trail
Scientific summaries are adapted from the supplied 15 October 2026 CRISPR Project Assessment. Source records show the original references and review access; this release is not a new systematic review.
C02 — Chen ACY, Ji KY, Yerinde C, et al. CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer. Cell. 29 July 2026.C08 — Jung H, Devant P, Ching C, et al. Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells. Nature Biotechnology. 17 August 2026.C09 — Jung H, Jeong B, Kim YW, et al. Precise genomic integration of large DNA fragments by donor-directed annealing using prime editing. Nature Biotechnology. 28 August 2026.Bring one question worth answering.
Tell us the decision, the evidence you have and the gap that blocks the next step. Start with nonconfidential context.